Indeed, these findings may have implications beyond neurogenic hypertension and may offer benefit in other diseases of sympathetic overactivity, such as modulation of renin–angiotensin–aldosterone release, chronic inflammatory diseases, and heart failure. This evidence concerns the gene REN and heart failure.